These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34603451)

  • 1. PDZ Binding Kinase/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors.
    Feng T; Zhang Y; Ling S; Xu C; Lyu Y; Lu T; Liu X; Ying L; Wan Y; Zhong H; Su D
    J Oncol; 2021; 2021():8892479. PubMed ID: 34603451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer.
    Zhang Y; Yang X; Wang R; Zhang X
    J Cancer; 2019; 10(1):131-137. PubMed ID: 30662533
    [No Abstract]   [Full Text] [Related]  

  • 4. An Integrative Pan-Cancer Analysis of PBK in Human Tumors.
    Wen H; Chen Z; Li M; Huang Q; Deng Y; Zheng J; Xiong M; Wang P; Zhang W
    Front Mol Biosci; 2021; 8():755911. PubMed ID: 34859049
    [No Abstract]   [Full Text] [Related]  

  • 5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers.
    Lee DH; Jeong YJ; Won JY; Sim HI; Park Y; Jin HS
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort.
    Liu Y; Xiang J; Peng G; Shen C
    Front Mol Biosci; 2021; 8():785370. PubMed ID: 34859058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
    Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.
    Chai Y; Xue H; Wu Y; Du X; Zhang Z; Zhang Y; Zhang L; Zhang S; Zhang Z; Xue Z
    Exp Ther Med; 2018 Jun; 15(6):4822-4828. PubMed ID: 29805502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
    PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
    Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.
    Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP
    Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value and Immunological Role of MORF4-Related Gene-Binding Protein in Human Cancers.
    Chai D; Zhang L; Guan Y; Yuan J; Li M; Wang W
    Front Cell Dev Biol; 2021; 9():703415. PubMed ID: 34660575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Diao X; Yang D; Chen Y; Liu W
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
    Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
    J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.